series-b
Stage
1
Investors
About
Walden Biosciences is a biotechnology company focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease, particularly by addressing kidney-specific cell types and biologic processes to restore renal function.
Explore Walden Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.